Leukotriene Modifiers: Nursing Pharmacology Study Guide

Leukotriene modifiers are oral controller medications used in the long-term management of asthma and allergic airway disease. This note reviews the three key drugs — montelukast, zafirlukast, and zileuton — along with their mechanism, uses, side effects, monitoring, and high-yield NCLEX safety points.

Drugs at a Glance

Mechanism of Action

• Leukotriene modifiers block the effects of leukotrienes, inflammatory mediators involved in asthma.
• They reduce airway inflammation, bronchoconstriction, and mucus production.
• The result is improved airway function and reduced asthma symptoms.

Drug Class Overview

• Leukotriene modifiers are oral controller medications used in asthma management.
• They are commonly used as add-on therapy for patients whose asthma is not well controlled with inhaled corticosteroids.
• They are not used for rapid relief of acute asthma attacks.

Indications & Guideline Notes

Leukotriene modifiers are used to treat:

• Persistent asthma
• Exercise-induced bronchospasm
• Allergic rhinitis

According to Global Initiative for Asthma (GINA) guidelines:

• Leukotriene receptor antagonists such as montelukast may be used as alternative or add-on controller therapy for mild persistent asthma.
• They can be useful in patients who cannot tolerate inhaled corticosteroids.
• They may help prevent exercise-induced bronchospasm when taken before physical activity.

Side Effects

• Common: headache and gastrointestinal upset.
• Rare but important: neuropsychiatric symptoms — mood changes, agitation, and depression — particularly with montelukast (FDA boxed warning).

Labs and Monitoring

Monitor patients for:

• Asthma symptom control
• Frequency of rescue inhaler use
• Liver function tests (LFTs) — specifically when using zileuton

Contraindications

Use cautiously in patients with:

• Liver disease
• Known hypersensitivity to the medication

Zileuton should be avoided in patients with significant liver dysfunction.

Pregnancy Safety

• Leukotriene receptor antagonists may be used during pregnancy if benefits outweigh potential risks.
• Maintaining asthma control during pregnancy is important for both maternal and fetal health.

Nursing Safety Rules & High-Yield NCLEX Notes

• Take leukotriene modifiers regularly for asthma control — not for acute symptom relief.
• These are NOT rescue medications for asthma attacks.
• Patients (and caregivers) should report any mood or behavioral changes while taking montelukast.

Key takeaways

• Leukotriene modifiers are oral controller drugs that block inflammatory mediators in asthma — not rescue medications.
• Montelukast is the most commonly used leukotriene receptor antagonist; zileuton is a synthesis inhibitor requiring LFT monitoring.
• Useful for persistent asthma, exercise-induced bronchospasm, and allergic rhinitis.
• Watch for neuropsychiatric side effects (mood changes, depression) — especially with montelukast.
• Acceptable in pregnancy when benefits outweigh risks, since asthma control protects both mother and fetus.